{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:20:15Z","timestamp":1794298815262,"version":"4.9.0"},"reference-count":54,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["101679"],"award-info":[{"award-number":["101679"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","award":["E!10124"],"award-info":[{"award-number":["E!10124"]}],"id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2025,10,12]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Annotation of liver biopsies for disease staging is increasingly aided by digital pathology; however, existing systems do not quantify inflammation and steatosis within an anatomical framework. We hypothesise that an artificial intelligence (AI) system that quantifies portal tracts (PT) and the anatomical distribution of steatotic vesicles and inflammatory cells will align with manual pathologist scoring and stratify liver diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this observational, cross-sectional study, digitised images of haematoxylin and eosin-stained specimens were pooled from four independent cohorts of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis (MASH) or autoimmune hepatitis (AIH) (n=390: 89 MASLD, 238 MASH, 63 AIH). PT, steatosis, and inflammation were quantified using a proprietary AI system and scored by expert pathologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The percentage of steatosis was higher in MASH (7.5%) than in MASLD (3.2%). Lobular regions had larger steatotic vesicles (260 vs 190\u2009\u03bcm\n                      <jats:sup>2<\/jats:sup>\n                      ). AI-derived steatosis quantification correlated with manual grading (r\n                      <jats:sub>s<\/jats:sub>\n                      =0.72). The inflammatory cell number (ICN) was twofold higher in AIH than MASLD\/MASH in interface (390 vs 140), portal (4600 vs 1500) and lobular (1500 vs 650) regions. Portal inflammation from manual grading correlated with ICN count at PT (r\n                      <jats:sub>s<\/jats:sub>\n                      =0.71) but not lobular regions (r\n                      <jats:sub>s<\/jats:sub>\n                      \u22640.29). For equivalent grades of portal inflammation, the ICN was up to threefold higher in AIH than in MASLD\/MASH (r\n                      <jats:sub>s<\/jats:sub>\n                      =0.71).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A new AI system for anatomical quantification of liver biopsy features measured variation in fat and inflammation across the lobule. It showed that inflammation burden was higher in AIH than MASLD\/MASH, despite equivalent portal grades, providing objective support for histological scoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2025-210311","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:25:56Z","timestamp":1761758756000},"page":"169-178","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH and AIH"],"prefix":"10.1136","volume":"79","clinical-trial-number":[{"clinical-trial-number":"nct03551522","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03198104","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03551522","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn39463479","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct03198104","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8188-6573","authenticated-orcid":false,"given":"Dylan","family":"Windell","sequence":"first","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Magness","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayden","family":"Beyer","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Thomaides","family":"Brears","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Larkin","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezia","family":"Hobson","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aljabar","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Fleming","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"},{"name":"University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Fryer","sequence":"additional","affiliation":[{"name":"Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-2786","authenticated-orcid":false,"given":"Timothy James","family":"Kendall","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Kainth","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Wakefield","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0730-7091","authenticated-orcid":false,"given":"Caitlin Rose","family":"Langford","sequence":"additional","affiliation":[{"name":"Perspectum Ltd, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bedossa","sequence":"additional","affiliation":[{"name":"LiverPat, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goldin","sequence":"additional","affiliation":[{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"2026021902550848000_79.3.169.1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026021902550848000_79.3.169.3","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004"},{"key":"2026021902550848000_79.3.169.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated Burden of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease in US Adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026021902550848000_79.3.169.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.02.001","article-title":"NAFLD and autoimmune hepatitis: Do not judge a book by its cover","volume":"75","author":"Dalekos","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2026021902550848000_79.3.169.6","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"2026021902550848000_79.3.169.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"2026021902550848000_79.3.169.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2036205"},{"key":"2026021902550848000_79.3.169.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"},{"key":"2026021902550848000_79.3.169.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24376"},{"key":"2026021902550848000_79.3.169.11","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"The Lancet"},{"key":"2026021902550848000_79.3.169.12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2022.01.011","article-title":"Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD","volume":"76","author":"Brunt","year":"2022","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.13","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201440"},{"key":"2026021902550848000_79.3.169.14","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207967"},{"key":"2026021902550848000_79.3.169.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31444-9"},{"key":"2026021902550848000_79.3.169.16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2020.08.014","article-title":"Liver biopsy reliability in clinical trials: Thoughts from a liver pathologist","volume":"73","author":"Brunt","year":"2020","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.025"},{"key":"2026021902550848000_79.3.169.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-20166-x","article-title":"A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression","volume":"8","author":"Perveen","year":"2018","journal-title":"Sci Rep"},{"key":"2026021902550848000_79.3.169.19","doi-asserted-by":"crossref","first-page":"106089","DOI":"10.1016\/j.compbiomed.2022.106089","article-title":"Artificial intelligence based liver portal tract region identification and quantification with transplant biopsy whole-slide images","volume":"150","author":"Yu","year":"2022","journal-title":"Comput Biol Med"},{"key":"2026021902550848000_79.3.169.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.015"},{"key":"2026021902550848000_79.3.169.21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-024-03301-2","article-title":"Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Pulaski","year":"2025","journal-title":"Nat Med"},{"key":"2026021902550848000_79.3.169.22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jhep.2024.11.032","article-title":"Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH","volume":"82","author":"Abdurrachim","year":"2025","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1109\/OJEMB.2024.3379479","article-title":"Lymphocyte-Infiltrated Periportal Region Detection With Structurally-Refined Deep Portal Segmentation and Heterogeneous Infiltration Features","volume":"5","author":"Tsai","year":"2024","journal-title":"IEEE Open J Eng Med Biol"},{"key":"2026021902550848000_79.3.169.24","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","article-title":"Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis","volume":"20","author":"Andersson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026021902550848000_79.3.169.25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpi.2024.100372","article-title":"Quantitative digital pathology enables automated and quantitative assessment of inflammatory activity in patients with autoimmune hepatitis","volume":"15","author":"Socha","year":"2024","journal-title":"J Pathol Inform"},{"key":"2026021902550848000_79.3.169.26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.575843","article-title":"Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis","volume":"11","author":"Dennis","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021902550848000_79.3.169.27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i7.609"},{"key":"2026021902550848000_79.3.169.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27560-5","article-title":"Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study","volume":"8","author":"McDonald","year":"2018","journal-title":"Sci Rep"},{"key":"2026021902550848000_79.3.169.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94754-9","article-title":"Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease","volume":"11","author":"Janowski","year":"2021","journal-title":"Sci Rep"},{"key":"2026021902550848000_79.3.169.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.031"},{"key":"2026021902550848000_79.3.169.31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321299"},{"key":"2026021902550848000_79.3.169.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010511"},{"key":"2026021902550848000_79.3.169.33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24127"},{"key":"2026021902550848000_79.3.169.34","first-page":"169","article-title":"Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis","volume":"151","author":"Vollmar","year":"1997","journal-title":"Am J Pathol"},{"key":"2026021902550848000_79.3.169.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.021"},{"key":"2026021902550848000_79.3.169.36","doi-asserted-by":"publisher","DOI":"10.1055\/a-2186-3557"},{"key":"2026021902550848000_79.3.169.37","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.32"},{"key":"2026021902550848000_79.3.169.38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29797"},{"key":"2026021902550848000_79.3.169.39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/liv.12162","article-title":"Hepatic steatosis estimated microscopically versus digital image analysis","volume":"33","author":"Hall","year":"2013","journal-title":"Liver Int"},{"key":"2026021902550848000_79.3.169.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"2026021902550848000_79.3.169.41","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000423","article-title":"Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Younossi","year":"2024","journal-title":"Hepatol Commun"},{"key":"2026021902550848000_79.3.169.42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cld.653","article-title":"Patterns of necrosis in liver disease","volume":"10","author":"Krishna","year":"2017","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2026021902550848000_79.3.169.43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.hepres.2005.09.018","article-title":"Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis","volume":"33","author":"Fukusato","year":"2005","journal-title":"Hepatol Res"},{"key":"2026021902550848000_79.3.169.44","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1111\/liv.16092","article-title":"Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology","volume":"44","author":"Naoumov","year":"2024","journal-title":"Liver Int"},{"key":"2026021902550848000_79.3.169.45","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(22)01214-4","article-title":"Evaluation of the performance of a novel digital pathology method for the continuous quantification of steatosis, ballooning and inflammation in liver biopsies and its correlation with NASH-CRN scores in patients with NASH","volume":"77","author":"Petitjean","year":"2022","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41374-019-0315-9","article-title":"Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD\/NASH","volume":"100","author":"De Rudder","year":"2020","journal-title":"Lab Invest"},{"key":"2026021902550848000_79.3.169.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"2026021902550848000_79.3.169.48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101472","article-title":"Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide","volume":"7","author":"Hartman","year":"2025","journal-title":"JHEP Rep"},{"key":"2026021902550848000_79.3.169.49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2025.01.032","article-title":"A phase IIb randomised-controlled trial of the FFAR1\/FFAR4 agonist icosabutate in MASH","volume":"83","author":"Harrison","year":"2025","journal-title":"J Hepatol"},{"key":"2026021902550848000_79.3.169.50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22724"},{"key":"2026021902550848000_79.3.169.51","first-page":"686","article-title":"Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis","volume":"54","author":"Dhingra","year":"2022","journal-title":"Pathology (Phila)"},{"key":"2026021902550848000_79.3.169.52","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.079145"},{"key":"2026021902550848000_79.3.169.53","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15217"},{"key":"2026021902550848000_79.3.169.54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cld.1228","article-title":"A review of histopathologic features of pediatric autoimmune liver disease","volume":"20","author":"Mau","year":"2022","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2025-210311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:55:47Z","timestamp":1771498547000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2025-210311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/jcp-2025-210311"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2025-210311","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}